Pacheco received multiple co-authored patents for novel gene therapy technologies at the Lentiviral
Research Group at Cell Genesys, Inc in Foster City, CA.
Objective: This application proposes experiments to address one of the greatest challenges in HIV vaccine research: how can broadly neutralising antibodies be induced by vaccination in humans to target pathogens such as HIV, which are resistant to traditional vaccine approaches The researcher and host labs will develop a mammalian display system using lentiviral
vectors to express HIV proteins on the surface of mammalian cells and allow the in vitro evolution of different candidate vaccine immunogens in the outgoing host lab of Prof.
vector-based vaccine achieved significant control of viral load in monkeys
2) Correction of CNI-iPS by ex vivo lentiviral
Omnia will provide lentiviral
vector technical services as well as manufacture of research grade through cGMP grade materials.
The bio pharmaceutical company Oxford BioMedica has been selected by healthcare specialist Novartis to make batches of a lentiviral
vector for immunotherapy programmes in a deal worth between Au2.
VIRxSYS Corporation announced today that the company has received a grant from the Maryland Stem Cell Research Commission to develop safer methods for induced pluripotent stem cell (iPS) using the company's proprietary spliceosome-mediated RNA trans-splicing (SMaRT[TM]) and lentiviral
gene delivery platform technologies.
M2 PHARMA-February 5, 2018-Avrobio Closes USD 60m Financing to Advance Gene Therapy Pipeline and Expand Lentiviral
The combined company will focus on developing and advancing its pipeline of gene therapies based on lentiviral
virus and adeno-associated virus gene therapy platforms, with a focus on treating devastating rare diseases.
In this study, Lentiviral
vector containing LXR[alpha] shRNAs were constructed and transferred in bovine muscle satellite cells.
The research team at ImmunoCellular successfully packaged a T cell receptor (TCR) DNA sequence into a lentiviral
vector, which was then used to transfect human hematopoietic stem cells.
Day 1: Development of a Lentiviral
Vector Platform for the Treatment of Chronic Ocular Disease